Targeting cervical cancer with anti-PD-1 antibodies: what is new?

被引：0
|
作者：
Greenman, Michelle [1 ]
Mcnamara, Blair [1 ]
Mutlu, Levent [1 ]
Santin, Alessandro D. [1 ,2 ]
机构：
[1] Yale Univ, Dept Obstet Gynecol & Reprod Sci, Sch Med, New Haven, CT USA
[2] Yale Univ, Obstet & Gynecol, Sch Med, 333 Cedar St, New Haven, CT 06520 USA
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2024年 / 24卷 / 03期
关键词：
cervical cancer; gynecologic malignancy; PD-1;
D O I：
10.1080/14712598.2024.2323596
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：111 / 114
页数：4
相关论文
共 50 条
  • [41] Pharmacokinetic analysis of anti-PD-1 and PD-L1 antibodies and evaluation of their anti-tumor effects
    Hatakeyama, Hiroto
    Kurino, Taiki
    Matsuda, Reiko
    Suzuki, Hiroyuki
    Terui, Ayu
    Uehara, Tomoya
    Arano, Yasushi
    Hisaka, Akihiro
    CANCER RESEARCH, 2019, 79 (13)
  • [42] Drug therapy of melanoma: anti-CTLA-4 and anti-PD-1 antibodies
    Robert, Caroline
    Mateus, Christina
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2014, 198 (02): : 297 - 308
  • [43] Longitudinal analysis of the landscape of cancer trials testing anti-PD-1/L1 monoclonal antibodies
    Tang, Jun
    Pearce, Laura
    O'Donnell-Tormey, Jill
    Hubbard-Lucey, Vanessa M.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [44] Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
    Swaika, Abhisek
    Hammond, William A.
    Joseph, Richard W.
    MOLECULAR IMMUNOLOGY, 2015, 67 (02) : 4 - 17
  • [45] Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy
    Garcia-Aranda, Marilina
    Redondo, Maximino
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [46] Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients
    Basak, Edwin A.
    van der Meer, Jan W. M.
    Hurkmans, Daan P.
    Schreurs, Marco W. J.
    Oomen-de Hoop, Esther
    van der Veldt, Astrid A. M.
    Bins, Sander
    Joosse, Arjen
    Koolen, Stijn L. W.
    Debets, Reno
    Peeters, Robin P.
    Aerts, Joachim G. J., V
    Mathijssen, Ron H. J.
    Medici, Marco
    THYROID, 2020, 30 (07) : 966 - 973
  • [47] STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance
    Li, Tianye
    Zhang, Weijiang
    Niu, Mengke
    Wu, Yuze
    Deng, Xinyue
    Zhou, Jianwei
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [48] Targeting novel regulated cell death: Ferroptosis, pyroptosis and necroptosis in anti-PD-1/PD-L1 cancer immunotherapy
    Yu, Li
    Huang, Ke
    Liao, Yixiang
    Wang, Lingzhi
    Sethi, Gautam
    Ma, Zhaowu
    CELL PROLIFERATION, 2024, 57 (08)
  • [49] The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer
    Patrinely, James Randall, Jr.
    Dewan, Anna K.
    Johnson, Douglas B.
    BIODRUGS, 2020, 34 (04) : 495 - 503
  • [50] The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer
    James Randall Patrinely
    Anna K. Dewan
    Douglas B. Johnson
    BioDrugs, 2020, 34 : 495 - 503
12345